在伴有慢性自发性荨麻疹发作期间，银屑病反复出现自发缓解。
Recurrent spontaneous clearance of psoriasis during exacerbations of concomitant chronic spontaneous urticaria.
作者信息
Magen Eli, Chikovani Tinatin
机构信息
Allergy and Clinical Immunology Unit Medicine C Department Barzilai Medical Center Ben Gurion University of Negev Ashkelon Israel.
Department of Immunology Tbilisi State Medical University Tbilisi Georgia.
出版信息
Clin Case Rep. 2020 May 25;8(8):1544-1546. doi: 10.1002/ccr3.2930. eCollection 2020 Aug.
Abstract
In this case report, we describe a patient with a chronological relationship between exacerbations of chronic spontaneous urticaria and remissions of concomitant generalized plaque psoriasis.
摘要
在本病例报告中，我们描述了一名慢性自发性荨麻疹发作与伴发的泛发性斑块状银屑病缓解之间存在时间顺序关系的患者。
相似文献
1
Recurrent spontaneous clearance of psoriasis during exacerbations of concomitant chronic spontaneous urticaria.在伴有慢性自发性荨麻疹发作期间，银屑病反复出现自发缓解。
Clin Case Rep. 2020 May 25;8(8):1544-1546. doi: 10.1002/ccr3.2930. eCollection 2020 Aug.
2
Coesisting inflammatory skin diseases: Tildrakizumab to control psoriasis and omalizumab for urticaria.合并存在的炎性皮肤病：使用替拉珠单抗控制银屑病，奥马珠单抗治疗荨麻疹。
Dermatol Ther. 2022 Apr;35(4):e15359. doi: 10.1111/dth.15359. Epub 2022 Feb 15.
3
Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis.慢性荨麻疹、银屑病和荨麻疹性血管炎患者血清D-二聚体水平的评估。
An Bras Dermatol. 2013 May-Jun;88(3):355-60. doi: 10.1590/abd1806-4841.20131532.
4
Long-term follow-up of patients treated with dupilumab for chronic spontaneous urticaria: A case report.度普利尤单抗治疗慢性自发性荨麻疹患者的长期随访：病例报告
SAGE Open Med Case Rep. 2022 Aug 16;10:2050313X221117702. doi: 10.1177/2050313X221117702. eCollection 2022.
5
Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria.与慢性自发性荨麻疹患者疾病严重程度和缓解时间相关的因素。
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):964-971. doi: 10.1111/jdv.14221. Epub 2017 Apr 4.
6
High prevalence and little awareness in patients with chronic inflammatory skin diseases and genital involvement.慢性炎症性皮肤病伴生殖器受累患者的高患病率和低知晓率。
J Dtsch Dermatol Ges. 2021 Oct;19(10):1443-1448. doi: 10.1111/ddg.14437. Epub 2021 Aug 16.
7
Recurrent oedema of the uvula in a patient with chronic spontaneous urticaria successfully treated with omalizumab.慢性自发性荨麻疹患者复发性悬雍垂水肿经奥马珠单抗成功治疗
J Dermatolog Treat. 2018;29(sup4):8-9. doi: 10.1080/09546634.2018.1550247.
8
[Spontaneous remission of urticaria: does it exist and if so, when?].[荨麻疹的自然缓解：是否存在以及何时发生？]
Dermatologie (Heidelb). 2024 Apr;75(4):303-308. doi: 10.1007/s00105-024-05320-z. Epub 2024 Mar 11.
9
Guideline-compliant prescription of biologicals and possible barriers in dermatological practices in Bavaria.巴伐利亚州皮肤科实践中符合指南的生物制剂处方和可能存在的障碍。
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):978-984. doi: 10.1111/jdv.14811. Epub 2018 Feb 7.
10
Two Track Biologic Therapy for Concurrent Chronic Spontaneous Urticaria and Psoriasis Vulgaris in One Patient.一名患者同时患有慢性自发性荨麻疹和寻常型银屑病的双轨生物疗法
Actas Dermosifiliogr. 2022 Nov-Dec;113(10):995-996. doi: 10.1016/j.ad.2021.02.029. Epub 2022 Jun 6.
引用本文的文献
1
Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders.了解银屑病及相关皮肤疾病的复杂病理生理学。
Int J Mol Sci. 2025 Jan 17;26(2):749. doi: 10.3390/ijms26020749.
本文引用的文献
1
Autoimmune Theories of Chronic Spontaneous Urticaria.慢性自发性荨麻疹的自身免疫理论。
Front Immunol. 2019 Mar 29;10:627. doi: 10.3389/fimmu.2019.00627. eCollection 2019.
2
Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of life.银屑病患者皮肤合并症的患病率及其对生活质量的影响。
Eur J Dermatol. 2019 Apr 1;29(2):192-196. doi: 10.1684/ejd.2019.3529.
3
Ketotifen suppression of NF1 neurofibroma growth over 30 years.30年来酮替芬对神经纤维瘤1型（NF1）神经纤维瘤生长的抑制作用。
Am J Med Genet A. 2015 Jul;167(7):1570-7. doi: 10.1002/ajmg.a.37045. Epub 2015 May 14.
4
New Insights in the Immunobiology of IL-1 Family Members.IL-1 家族成员的免疫生物学新见解。
Front Immunol. 2013 Jul 8;4:167. doi: 10.3389/fimmu.2013.00167. eCollection 2013.
5
Clinical and laboratory features of chronic idiopathic urticaria in the elderly.老年人慢性特发性荨麻疹的临床和实验室特征
Int J Dermatol. 2013 Nov;52(11):1387-91. doi: 10.1111/ijd.12109. Epub 2013 Jul 8.
6
The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis.糜酶小鼠肥大细胞蛋白酶 4 降解 TNF，限制炎症，并在脓毒症模型中促进存活。
Am J Pathol. 2012 Sep;181(3):875-86. doi: 10.1016/j.ajpath.2012.05.013.
7
T cell-mediated modulation of mast cell function: heterotypic adhesion-induced stimulatory or inhibitory effects.T 细胞介导的肥大细胞功能调节：异型黏附诱导的刺激或抑制作用。
Front Immunol. 2012 Jan 30;3:6. doi: 10.3389/fimmu.2012.00006. eCollection 2012.
8
Is there a role for mast cells in psoriasis?肥大细胞在银屑病中起作用吗？
Arch Dermatol Res. 2008 Oct;300(9):461-78. doi: 10.1007/s00403-008-0874-x. Epub 2008 Aug 22.
9
Mast cells are essential intermediaries in regulatory T-cell tolerance.肥大细胞是调节性T细胞耐受性的重要中介。
Nature. 2006 Aug 31;442(7106):997-1002. doi: 10.1038/nature05010. Epub 2006 Aug 20.
10
Innate and adaptive immunity and the pathophysiology of psoriasis.先天性和适应性免疫与银屑病的病理生理学
J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S67-80. doi: 10.1016/j.jaad.2005.10.057.
Zotero 插件